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Resistance exercise initiates 
mechanistic target of rapamycin 
(mTOR) translocation and protein 
complex co-localisation in human 
skeletal muscle
Zhe Song1, Daniel R. Moore2,3, Nathan Hodson1, Carl Ward4, Jessica R. Dent1, Mary F. 
O’Leary5, Andrew M. Shaw6, D. Lee Hamilton6, Sovan Sarkar4, Yann-Gaël Gangloff7, Troy A. 
Hornberger8, Lawrence L. Spriet3, George J. Heigenhauser9 & Andrew Philp1
The mechanistic target of rapamycin (mTOR) is a central mediator of protein synthesis in skeletal 
muscle. We utilized immunofluorescence approaches to study mTOR cellular distribution and protein-
protein co-localisation in human skeletal muscle in the basal state as well as immediately, 1 and 3 h after 
an acute bout of resistance exercise in a fed (FED; 20 g Protein/40 g carbohydrate/1 g fat) or energy-free 
control (CON) state. mTOR and the lysosomal protein LAMP2 were highly co-localised in basal samples. 
Resistance exercise resulted in rapid translocation of mTOR/LAMP2 towards the cell membrane. 
Concurrently, resistance exercise led to the dissociation of TSC2 from Rheb and increased in the co-
localisation of mTOR and Rheb post exercise in both FED and CON. In addition, mTOR co-localised 
with Eukaryotic translation initiation factor 3 subunit F (eIF3F) at the cell membrane post-exercise in 
both groups, with the response significantly greater at 1 h of recovery in the FED compared to CON. 
Collectively our data demonstrate that cellular trafficking of mTOR occurs in human muscle in response 
to an anabolic stimulus, events that appear to be primarily influenced by muscle contraction. The 
translocation and association of mTOR with positive regulators (i.e. Rheb and eIF3F) is consistent with 
an enhanced mRNA translational capacity after resistance exercise.
Resistance training is an effective strategy to increase muscle strength and muscle hypertrophy, with the latter 
ultimately mediated by an exercise-induced increase in muscle protein synthesis and net protein balance1. Skeletal 
muscle protein balance is generally dependent on the activity of the serine/threonine protein kinase mechanistic 
target of rapamycin (mTOR), which when active stimulates protein synthesis and attenuates protein degrada-
tion2. mTOR exists as 1 of 2 complexes (mTORC1 and mTORC2), with their respective substrate preference and, 
ultimately, biological activity related to the specific associated subunits2. For example, mTORC1 contains mTOR, 
GβL, raptor, DEPTOR and PRAS40 and is inhibited by the bacterial macrolide rapamycin2. In contrast, mTORC2 
consists of mTOR, rictor, GβL, Sin1, DEPTOR and Protor/PRR5 and is insensitive to acute rapamycin adminis-
tration2. Although each mTOR complex responds to unique subsets of biological stimuli and generally localize 
to different subcellular compartments3, mTORC1 is the most widely studied of the two complexes and responds 
to anabolic stimuli such as insulin, amino acids, and/or resistance exercise2. For example, acute administration 
of rapamycin blocks the independent anabolic effects of resistance exercise and amino acid ingestion on mTOR 
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signaling molecule phosphorylation and subsequently protein synthesis in human skeletal muscle4, 5. Collectively, 
these data highlight a pivotal role for mTORC1 activity in the regulation of muscle protein synthesis in response 
to resistance exercise and amino acid ingestion.
Current understanding regarding the physiological regulation of mTOR in human skeletal muscle has resulted 
in large part from phosphorylation-specific profiling of the mTOR pathway in response to anabolic stimuli6. 
Consistent with the ability of resistance exercise to increase muscle protein synthesis in the fasted state7, 8, phos-
phorylation of mTOR substrates (as a proxy for mTOR activity) has indicated that mTOR is activated following 
resistance exercise9, with this response maintained for at least 24 h post-exercise10. Moreover, the provision of exog-
enous amino acids (either orally or intravenously) augments post-exercise rates of muscle protein synthesis11, 12, 
which is generally coincident with changes in phosphorylation status of proteins within the mTOR signaling 
cascade that are consistent with enhanced translational activity13, 14.
Beyond immunoblotting approaches, in vitro studies have indicated that cellular localization and 
protein-protein interaction may be fundamentally important in the regulation of mTOR activity in response to 
physiological stimuli3. Following mitogen or amino acid stimulation in vitro, mTOR has been observed to trans-
locate to the lysosome where it associates with GTP bound ras-homolog enriched in brain (Rheb) to achieve full 
activation15. In contrast, amino acid removal results in mTOR dissociation from the Rag GTPases and hence the 
lysosome, subsequently rendering it inactive15. mTOR interaction with Rheb is restricted in basal conditions due 
to the enzymatic activity of the tuberous sclerosis complex proteins TSC1 and TSC2, which maintain Rheb in a 
GDP-bound state16. However, phosphorylation of TSC2 by AKT leads to TSC2 inactivation17, Rheb-TSC2 disso-
ciation, GTP-loading of Rheb and interaction with mTOR18. Jacobs and coworkers recently reported that mTOR 
and TSC2 associate at the lysosome in mouse tibialis-anterior skeletal muscle, with eccentric contractions stim-
ulating an increase in mTOR-lysosomal localisation and subsequent dissociation of TSC2 from the lysosome19. 
Collectively these studies would suggest that targeting of mTOR to the lysosome is a fundamentally important 
event to initiate cellular protein synthesis20.
The goal of the present study was to examine cellular distribution and co-localization of proteins involved in 
mTOR complex assembly/activity in human skeletal muscle in response to resistance exercise. In addition, we also 
evaluated the effect of post-exercise protein/carbohydrate ingestion on mTOR complex assembly and localisation. 
We hypothesized that resistance exercise would increase mTOR abundance at the lysosomal surface to facilitate 
interaction with Rheb and that post-exercise nutrients would augment these responses.
Results
Determining mTOR, Rheb, TSC2 and eIF3F antibody specificity in human skeletal muscle. To 
determine the specificity of antibodies towards mTOR and mTOR-associated proteins, we performed a number of 
validation approaches. To test the specificity of the mTOR, Rheb and TSC2 antibody, labelling experiments were 
performed in skeletal muscle from wild-type vs. whole-body mTOR knock-out21 and muscle-specific, tamox-
ifen-inducible Rheb and TSC2 mouse22 models (Fig. 1). For each protein, sensitivity to the endogenous protein 
was evident through a ~50% loss of signal in the KO/mKO sample (Fig. 1), whilst the remaining signal could 
be attributed to non-specific binding or heightened background due to species cross-reactivity. To test the anti-
bodies specifically in human skeletal muscle, further validation was then performed using peptide competition 
assays (Rheb/eIF3F), or using the recombinant protein used in the antibody synthesis (TSC2) (Fig. 2). Finally, we 
Figure 1. mTOR, Rheb and TSC2 antibody validation. Immunofluorescence labeling of endogenous proteins 
was performed as described in the Methods section. Cross-sections were stained with the antibodies relating 
to mTOR, Rheb and TSC2 in wild-type mice (WT – Left panel) or in muscle from mTOR, Rheb and TSC2 
knockout mice (mKO). Regionality of staining is provided through co-staining with WGA or Dystrophin as a 
marker of the cell membrane. All image processing was kept constant between images, including exposure time, 
gain, and image frame. GS – Grey scale image *Significantly different to WT (P < 0.05).
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examined non-specific binding of each antibody through omitting the primary antibody (Fig. 2). In each case we 
demonstrate that the antibodies used show specificity to their target protein (Figs 1 and 2).
Synergistic effect of resistance exercise and post-exercise nutrition on S6K1 and AKT activ-
ity. S6K1 activity was rapidly increased post-exercise in both groups, with this response augmented in the FED 
group 1 h post exercise compared to control (CON: 3-fold; FED: 10-fold). In parallel, AKT kinase activity was 
rapidly increased post exercise in both groups, with this response significantly higher in the FED group 1 h post 
exercise (CON: 1-fold; FED: 6-fold)(Fig. 3).
mTOR/LAMP2 co-localisation and cellular distribution in basal and exercise-stimulated human 
skeletal muscle. The total amount of mTOR did not change during the experimental time course in either 
the CON or FED groups (data not shown). mTOR and LAMP2 were found to be highly colocalised in human 
skeletal muscle in both basal and exercise stimulated conditions suggesting that mTOR is located in close prox-
imity to the late-lysosome in basal skeletal muscle (Fig. 4A). In both CON and FED we observed relocation of 
mTOR from cytosolic regions to the sarcolemmal membrane following resistance exercise as quantified by mTOR 
Figure 2. Rheb, TSC2 and eIF3F peptide competition assays. Immunofluorescence labeling of endogenous 
proteins was performed in human basal samples (CON – Left panel) as described in the Methods section. 
Regionality of staining is provided through co-staining with WGA or Dystrophin as a marker of the cell 
membrane. Competition (COMP) assays were performed to demonstrate antibody specificity of TSC2, eIF3F 
and Rheb. Non-specific binding/antibody efficiency was examined through imaging samples in which secondary 
antibody was used without prior primary antibody incubation (No Ab). All image processing was kept constant 
between images, including exposure time, gain, and image frame. *Significantly different to CON (P < 0.05).
Figure 3. Post-exercise activation of S6K1 and AKT are augmented by PRO/CHO ingestion. Resistance 
exercise increased S6K1 activity, with this response significantly higher in the FED group 1 h post exercise (A). 
In parallel, AKT kinase activity was increased post exercise, with this response significantly higher in the FED 
group 1 h post exercise (B). Data presented as mean ± SEM (n = 7/group). *Significantly different to PRE-CON, 
§Significantly different to PRE-FED, ΦSignificantly different to 1h-CON (P < 0.05).
www.nature.com/scientificreports/
4Scientific RepoRts | 7: 5028  | DOI:10.1038/s41598-017-05483-x
localisation with WGA positive regions, with a ~20% increase in membrane associated mTOR observed across 
all post-exercise time points (Fig. 4B). In parallel, we observed relocation of LAMP2 from cytosolic regions to the 
sarcolemmal membrane following resistance exercise as quantified by LAMP2 localisation with WGA positive 
regions, with a ~20% increase in membrane associated LAMP2 observed across all post-exercise time points 
(Fig. 4C). To examine the potential physiological relevance of mTOR translocation to the plasma membrane, we 
examined mTOR co-localisation with nuclei and blood vessels. Whilst mTOR did not associate with the nucleus 
post exercise (DAPI positive regions - data not shown), we did observe mTOR accumulating in regions close to 
the blood capillary endothelium as determined via UEA-I Lectin positive staining (Fig. 5).
TSC2 dissociates from Rheb and plasma membrane regions post-exercise. TSC2 and Rheb were 
found to associate in close proximity to the plasma membrane in pre-exercise samples in both the CON and 
FED groups (Fig. 6). Following contraction, TSC2 and Rheb association decreased by ~20% across the entire 
post-exercise recovery period in both the CON and FED groups (Fig. 6). The dissociation of TSC2 and Rheb post 
exercise appeared to be mediated by TSC2 export from the cell membrane as we observed a ~30% decrease in 
TSC2 association with the plasma membrane (Fig. 7) post exercise in both the CON and FED groups.
mTOR co-localises with Rheb and eIF3f post-exercise. Given that mTOR/LAMP2 complexes were 
observed to re-locate to the plasma membrane post-exercise, we next examined whether mTOR redistribution 
might facilitate association with proteins implicated in mTOR activity. The most characterised positive regulator of 
mTOR is the GTPase Rheb. We observed a ~30% increase in mTOR and Rheb co-localisation post exercise in both 
the CON and FED groups (Fig. 8). To examine whether mTOR translocation to the membrane facilitated inter-
action with factors associated with protein synthesis we examined mTOR and eIF3F co-localisation. Resistance 
exercise resulted in rapid and sustained increases in mTOR association with eIF3F in both the CON and FED 
groups. Interestingly, the magnitude of association between mTOR and eIF3F was ~20% greater in the FED group 
1 h post exercise compared to CON, suggesting that this process is sensitive to post-exercise nutrition (Fig. 9).
Figure 4. mTOR/LAMP2 complex translocation to the cell membrane following resistance exercise. 
Representative image of mTOR (Red), LAMP2 (Green), composite image of mTOR and LAMP2 (Merge) and 
WGA (Blue) for one subject from CON across the experimental time course. Yellow regions represent mTOR 
and LAMP2 interaction. Immunofluorescence quantification of mTOR and LAMP2 Co-localization (A), 
quantification of mTOR associated with the cell membrane marker WGA (B) and quantification of LAMP2 
associated with WGA (C). Circles represent CON, squares represent FED. All image processing was kept 
constant between images, including exposure time, gain, and image frame. All data presented relative to the Pre 
exercise CON. Data presented as mean ± SEM (n = 7/group). *Significantly different to PRE-CON (P < 0.05).
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Discussion
The protein complex mTORC1 is critical for regulating skeletal muscle mass23. Numerous studies in humans have 
demonstrated that mTORC1 activity is increased during the post-exercise period both with and without nutrient 
(e.g. amino acids) ingestion1. Inhibition of mTORC1 activity using the mTORC1 specific inhibitor rapamycin 
blocks resistance-exercise mediated increases in protein synthesis, indicating that mTORC1 activity is required 
to activate muscle protein synthesis in humans4, 5. Despite this body of work, additional research is warranted to 
better understand how mTORC1 is activated in human skeletal muscle in response to anabolic stimuli such as 
resistance exercise (both with and without nutrient ingestion) and how mTORC1 activates pathways regulating 
mRNA translation and, hence, muscle protein synthesis24. To this end, utilising immunofluorescence approaches 
in human skeletal muscle we have detailed, for the first time, intracellular mTOR localisation and protein complex 
co-localisation in response to an anabolic stimulus. We demonstrate that mTOR co-localises with the lysosome 
in basal conditions and that these complexes translocate to the cell periphery, in close proximity to capillaries, in 
response to resistance exercise. In parallel, we also observed that resistance exercise stimulates TSC2 dissociation 
from Rheb and that this leads to a reduction in TSC2 abundance at the cell membrane, which would be consistent 
Figure 5. mTOR translocates to the microvasculature following resistance exercise. Immunofluorescence 
quantification of mTOR (Red) and UEA-I (Green) interaction, displayed as a composite image (Merge) and 
WGA (Blue). Yellow regions represent mTOR and UEA-I interaction. Each panel represents one subject from 
CON and FED across the experimental time course (A). Group data is quantified and reported in (B). Circles 
represent CON, squares represent FED. All image processing was kept constant between images, including 
exposure time, gain, and image frame. All data presented relative to the Pre exercise CON. Data presented as 
mean ± SEM (n = 7/group). *Significantly different to PRE-CON (P < 0.05).
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with enhanced mTOR kinase activity. Although post-exercise ingestion of PRO/CHO had little effect on mTOR 
translocation or TSC2-Rheb-mTOR association, nutrient ingestion did increase mTOR and eIF3F association 
post exercise; this interaction may contribute to greater S6K1 kinase activity in the present study and the previ-
ously well-documented enhancement of muscle protein synthesis after exercise in the fed state11, 12.
Recent work from the Hornberger lab19 in mice has suggested that recruitment of the catalytic component 
of mTORC1 (mTOR) to the late lysosomal membrane is an important event initiating the protein synthetic 
response. We therefore sought to utilise immunofluorescence approaches to detail this event in human skeletal 
muscle in response to resistance exercise during a post-exercise period in which rates of muscle protein synthesis 
are known to be elevated7, 8. Additionally, we investigated whether consumption of a protein/carbohydrate bev-
erage post exercise, which would further enhance the muscle protein synthetic response14, 25, 26, would augment 
the mTOR compartmentalisation during recovery compared to an energy-free control. In contrast to cell and 
rodent studies, we observed co-localisation of mTOR with the lysosome in basal conditions, an interaction that is 
retained during the 3 h post-exercise recovery period independently of concomitant protein/carbohydrate inges-
tion. Thus, recruitment of mTOR to the late-lysosome compartment does not appear to be enhanced relative to 
Figure 6. TSC2 and Rheb dissociate following resistance exercise. Immunofluorescence quantification of 
TSC2 (Red) and Rheb (Green) interaction, displayed as a composite image (Merge) and WGA (Blue). Yellow 
regions represent TSC2 and Rheb interaction. Each panel represents one subject from CON and FED across 
the experimental time course (A). Group data is quantified and reported in (B). Circles represent CON, squares 
represent FED. All image processing was kept constant between images, including exposure time, gain, and 
image frame. All data presented relative to the Pre exercise CON. Data presented as mean ± SEM (n = 7/group). 
*Significantly different to PRE-CON (P < 0.05).
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basal conditions in response to anabolic stimuli such as amino acids and/or muscle contraction in human skeletal 
muscle, which is in contrast to reports in cell15 and rodent19 models. The explanation for the discrepancy between 
the present and previous data is not readily apparent; however, differences in nutrient availability in human skele-
tal muscle compared to cell-based models may play a role. For example, dissociation of mTOR from the lysosome 
in cell-based models has been observed in amino acid free conditions15, which is a scenario that would be more 
reflective of chronic fasting that could initiate an autophagic response27. Interestingly, in the same in vitro model, 
mild amino acid reduction does not result in mTOR dissociation from the lysosome and therefore mTOR activ-
ity is unaltered27. Similar results could also be expected in human muscle given that muscle protein breakdown 
(as part of the normal ‘turnover’ of muscle protein pools) functions to replenish the intracellular amino acid 
pool to support rates of basal muscle protein synthesis28, as such, even in the fasted state there may be sufficient 
intracellular amino acids to maintain mTOR localization with the lysosomal membrane. Thus, constant mTOR 
association with the lysosome may reflect amino acid availability and the requirement of mTOR to maintain basal 
protein synthesis in resting human skeletal muscle.
Our initial hypothesis was that mTOR translocation to the lysosome would be the key activation event for 
mTOR in response to an exercise stimulus. In contrast, our data demonstrate that mTOR/LAMP2 translocation 
to the cell periphery is a principal event relocating mTOR following resistance exercise. The direct physiological 
Figure 7. TSC2 dissociates from the plasma membrane following resistance exercise. Immunofluorescence 
quantification of TSC2 (Red) and the plasma membrane marker WGA (Blue). Each panel represents one 
subject from CON and FED across the experimental time course (A). Group data is quantified and reported in 
(B). Circles represent CON, squares represent FED. All image processing was kept constant between images, 
including exposure time, gain, and image frame. All data presented relative to the Pre exercise CON. Data 
presented as mean ± SEM (n = 7/group). *Significantly different to PRE-CON (P < 0.05).
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relevance of this event is currently unclear, however it has previously been suggested that lysosome migration 
to the cell periphery can act as a stimulus for mTORC1 activation27. For example, overexpression of two kinesin 
superfamily members (KIF1Bβ and KIF2) that target lysosomes to the cell periphery increased mTORC1 activ-
ity27. In contrast, siRNA-mediated knockdown of KIF1Bβ and KIF2 targeted lysosomes to peri-nuclear regions, 
which subsequently reduced mTORC1 activity and initiated autophagy27. As such, lysosomal distribution would 
appear to be a key initial event in the increased activity of mTOR in response to nutrient stimulation. It is pos-
sible that the exercise-induced mTOR complex migration reported herein may also function to situate mTOR 
adjacent to ribosomal RNA29, the ribosomal pool30, 31 and ribosomal associated proteins32 reported to localise in 
this region. By doing so, this translocation event would position mTOR in close proximity to its target substrates 
and associated proteins required for protein synthesis and translation initiation. Support for this hypothesis can 
be observed in the elegant work of Goodman and colleagues who utilised the SUnSET technique to demonstrate 
that protein synthesis in mature skeletal muscle fibres in vivo occurs predominantly at the plasma membrane with 
a more diffuse signal in the intermyofibrillar region32, 33. When coupled with our data regarding mTOR migra-
tion and the known peripheral localization of the myonuclei and associated endoplasmic reticula, these studies 
Figure 8. Resistance exercise increases mTOR and Rheb co-localisation at the plasma membrane. 
Immunofluorescence quantification of mTOR (Red) and Rheb (Green) interaction, displayed as a composite 
image (Merge) and WGA (Blue). Yellow regions represent mTOR and Rheb interaction. Each panel represents 
one subject from CON and FED across the experimental time course (A) Group data is quantified and reported 
in (B) Circles represent CON, squares represent FED. All image processing was kept constant between images, 
including exposure time, gain, and image frame. All data presented relative to the Pre exercise CON. Data 
presented as mean ± SEM (n = 7/group). *Significantly different to PRE-CON (P < 0.05).
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collectively support a model in which the cell periphery is an active hub to support mRNA translation and protein 
synthesis in skeletal muscle. Our finding of a similar mTOR/LAMP2 translocation event following resistance 
exercise that is uninfluenced by protein/carbohydrate ingestion would suggest that mTOR/LAMP2 translocation 
is important for the initial activation of mRNA translation after exercise in human skeletal muscle.
Previous studies have demonstrated that mTOR interaction with GTP bound Rheb is required to elicit com-
plete mTORC1 activation34. Rheb is a small GTPase34 and is activated by the GTPase activating protein TSC2, 
which converts GTP-Rheb into GDP-Rheb rendering it unable to activate mTORC118, 35. Rheb is able to bind to 
the catalytic domain of mTOR36, 37 only when associated with GTP38. It was recently reported that eccentric con-
traction in mouse skeletal muscle leads to TSC2 dissociation from the lysosome, which would facilitate the mTOR 
and GTP-Rheb interaction19. In contrast, we observed TSC2 to be located at the plasma membrane, co-localising 
with Rheb as opposed to the two proteins associating at the lysosome. In our hands, TSC2 dissociated from 
the membrane following resistance exercise, leaving Rheb and the mTOR/LAMP2 complex to co-localise. It is 
unclear why the location of this event is different in human as opposed to murine skeletal muscle but may be 
Figure 9. Resistance exercise increases mTOR and eIF3F co-localisation at the plasma membrane. 
Immunofluorescence quantification of mTOR (Red) and eIF3F (Green) interaction, displayed as a composite 
image (Merge) and WGA (Blue). Yellow regions represent mTOR and eIF3F interaction. Each panel represents 
one subject from CON and FED across the experimental time course (A). Group data is quantified and reported 
in (B). Circles represent CON, squares represent FED. All image processing was kept constant between images, 
including exposure time, gain, and image frame. All data presented relative to the Pre exercise CON. Data 
presented as mean ± SEM (n = 7/group). *Significantly different to PRE-CON (P < 0.05). §Significantly different 
between groups (P < 0.05).
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reflective of muscle fibre-type differences (predominantly fast-twitch in mouse vs mixed fibres in human), the 
mode of exercise (eccentric vs concentric/eccentric), the degree of contraction or fibre recruitment, the nutri-
ent availability in each scenario, and/or interspecies differences. Irrespective, our data are in agreement with 
Jacobs et al. reporting that TSC2 dissociation from mTOR positive regions19 and appears to be a key post-exercise 
event following an anabolic stimulus in human skeletal muscle. TSC2 dissociation from Rheb is thought to occur 
primarily via AKT-mediated phosphorylation16, 39. In support, we observed AKT kinase activity to be rapidly 
increased in skeletal muscle in both groups, peaking 1 h post exercise. This signalling was concomitant with dis-
sociation of TSC2 from Rheb and a reduction in TSC2 at the cell membrane. However, there was no difference in 
TCS2/Rheb colocalization (or WGA-associated TSC2 signal) between the CON and FED groups at 1 h despite the 
large difference in AKT and S6K1 activity. This discrepancy could be related to a dissociated anabolic signalling 
response40, a greater methodological sensitivity for the activity rather than action (e.g. TSC2/Rheb dissociation) 
of AKT (i.e. kinase assay vs. immunofluorescence), and/or indicate that alternative kinases may regulate TSC2 
activity in skeletal muscle, as has recently been proposed22, 41.
In addition to TSC2-Rheb-mTOR co-localisation, we next sought to examine whether mTOR translocation to 
the plasma membrane may serve to direct mTOR/LAMP2 to other substrates involved in the initiation of protein 
synthesis. We report novel data indicating that mTOR associates with the regulatory subunit of the eukaryotic 
initiation factor 3 complex, eIF3F, post-exercise in both the CON and FED groups. The eIF3 complex is key to 
the initiation of protein synthesis serving as a scaffold for mTOR and S6K1 interaction, leading to the assembly of 
the pre-initiation complex42, 43. mTOR and eIF3F co-localisation occurred rapidly post-exercise in both the CON 
and FED groups, which is consistent with the ability of resistance exercise to enhance amino acid uptake and 
muscle protein synthesis early in recovery7, 44. However this association was significantly greater in the FED group 
1 h post exercise, suggesting that feeding may enhance mTOR-eIF3F assembly post-exercise. Given that muscle 
protein synthesis and the phosphorylation of mTORC1 substrates is amplified post-exercise following protein/
carbohydrate ingestion14, 26, it would appear that the increased mTOR-eIF3F interaction observed in the FED 
group may be an important mediator of post-exercise nutrition on mTORC1 dependent signaling and potentially 
muscle protein synthesis. In support, both upstream (AKT) and downstream (S6K1) mTORC1-dependent kinase 
activity was enhanced by feeding in the present study, which would be in agreement with previous observations45 
and consistent with a greater translational activity with protein/carbohydrate ingestion.
In addition, we also observed that mTOR/LAMP2 complexes associated with the microvasculature (UAE-I posi-
tive regions) at the plasma membrane post exercise. The precise reason for this response is currently unclear, however 
mTOR association with the microvasculature would in theory position mTOR in close proximity to nutrient provi-
sion delivered from the bloodstream. mTOR interaction with UEA-I positive cells increased equally post-exercise 
in both the CON and FED groups suggesting that mTOR interaction with the microvasculature is not influenced 
by protein/carbohydrate ingestion in healthy young men after exercise. Collectively, this adds further support to the 
hypothesis that mTOR translocation is a mechanically driven event and that protein/carbohydrate facilitates mTOR 
interaction with protein partners (eIF3F) rather than altering the localisation of mTOR/LAMP2 complexes.
Limitations and technical considerations. The present study is the first to examine mTOR protein 
complex co-localisation in human skeletal muscle using immunofluorescence approaches. This novel approach 
provides a powerful tool to examine the relevance of cellular distribution and protein interaction for mTORC1 
function, data currently lacking in the field. However, we would be remiss if we did not highlight that this 
approach relies heavily on immunofluorescence approaches, and by extension the specificity of the antibodies 
used. In an attempt to add confidence to our data and validate the specificity of each antibody, we performed 
competition assays with antigen specific peptides/recombinant proteins and used skeletal muscle from mTOR, 
Rheb and TSC2 knockout mice21, 22. These assays demonstrated specificity of the antibodies to their protein tar-
gets (i.e the signal was reduced in mKO vs WT), however they did also highlight non-specific binding that may 
have influenced our data. For example, use of mKO mouse tissue lead to an ~50% reduction the signal intensity 
of mTOR, TSC2 and Rheb, suggesting that the remaining signal could be attributed to non-specific binding of 
the antibodies used. Extending this observation into human skeletal muscle is challenging given potential species 
cross-reactivity of each antibody, histological differences in mouse vs human skeletal muscle (i.e fibre-type varia-
tion), in addition to contamination from other cell types. We attempted to bridge this gap by performing peptide/
recombinant protein competition assays in human skeletal muscle. This approach was successful in blocking 
antibody binding to its target protein, however again cannot directly address the issue of non-specific binding. 
Collectively, therefore, whilst the approaches we used are considered ‘gold standard’ for the field, interpretative 
caution to our data should be employed given the potential for non-specific biding to have occurred, thus influ-
encing our results. Whilst non-specific binding is a clear limitation of immunofluorescence approaches, the goal 
of this present study was to conduct a novel investigation into the localisation of mTOR and associated proteins, a 
task impossible using other analytical techniques. Therefore, despite the inherent limitations of immunofluores-
cent labelling in human skeletal muscle, we believe confidence can be taken from our results given our data shows 
mTOR and mTOR-related proteins to localize in specific patterns within the cell, interact with characterized pro-
tein partners, and translocate in a time-dependent manner in response to a physiological stimulus, all consistent 
with our current understanding of mTOR biology.
In summary, utilising immunofluorescence approaches in human skeletal muscle, we have detailed for the 
first time intracellular mTOR localisation and protein complex co-localisation in response to an anabolic stim-
ulus. We demonstrated that mTOR co-localised with the lysosome in basal conditions and that these complexes 
translocated to the cell periphery in response to resistance exercise. In parallel, resistance exercise stimulates 
TSC2 dissociation from Rheb and leads to a reduction in TSC2 abundance at the cell membrane, which would 
be consistent with an enhanced mTOR kinase activity. Although post-exercise ingestion of protein/carbohydrate 
had little effect on mTOR translocation or TSC2-Rheb-mTOR co-localisation, nutrient ingestion did increase 
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mTOR and eIF3F association as well as S6K1 kinase activity post exercise; an effect that may contribute to the 
well-documented enhancement of muscle protein synthesis after exercise in the fed state. Collectively, our data 
highlight the potential importance of mTOR-lysosomal cellular partitioning for mTORC1 function following a 
growth stimulus and illustrate another level of complexity to the molecular control of protein synthesis following 
resistance exercise and nutrition in human skeletal muscle. Future studies could include concurrent measures 
of muscle protein synthesis and effector enzyme activity45 to further elucidate the physiological significance of 
mTORC1 complex assembly and intracellular translocation in human skeletal muscle after exercise.
Methods
Subjects. Fourteen healthy, recreationally active males volunteered to participate in the study. Participants 
were informed about the experimental procedure to be used as well as the purpose of the study and all potential 
risks prior to obtaining written consent. All participants were deemed healthy based on their response to a routine 
medical screening questionnaire. All participants were recreationally active and reported performing resistance 
exercise with their lower body at least once per week. The study carried approval by the local Research Ethics 
Board of McMaster University and Hamilton Health Sciences and the University of Guelph Research Ethics Board 
and conformed to all standards for the use of human subjects in research as outlined in the Declaration of Helsinki.
Experimental Design. Participants were randomly assigned into groups that received either a 
protein-carbohydrate beverage (FED; n = 7, age = 25 ± 2 y, BMI = 26.1 ± 2.3 kg/m2; means ± SD) or an 
energy-free control (CON; n = 7, age = 24 ± 3 y, BMI = 26.3 ± 2.6 kg/m2) after exercise. Participants reported to 
the laboratory after an overnight fast having refrained from strenuous exercise for at least 48 h. A single biopsy 
was taken from the vastus lateralis of a randomly selected thigh under local anesthesia (2% xylocaine), as pre-
viously described46. Participants performed an intense bout of bilateral leg resistance exercise consisting of 5 
sets each of leg press and knee extension (with an inter-set rest period of 2-min) using a predetermined weight 
that elicited voluntary failure in 8–10 repetitions. Similar exercise protocols have been shown to elicit a robust 
increase in muscle protein synthesis over 3 h of recovery in both the fasted47 and fed states25. A second muscle 
biopsy was taken 10 min after completion of the exercise bout from the same thigh as the first biopsy to determine 
mTOR co-localization early in recovery. Participants were then randomly assigned to consume a commercially 
available beverage (Gatorade Recover®, Gatorade, IL, USA) providing 20/44/1 g of protein/carbohydrate/fat 
(FED) or an energy-free control (CON). As such, the 20 g of high quality milk-based protein consumed by FED 
would be expected to maximize muscle protein synthesis48 and the 44 g of carbohydrate would elicit a marked 
insulin response26 to enhance mTOR signalling40. Subsequently, muscle biopsies were taken 1 and 3 h after the 
beverage ingestion from separate incisions on the contralateral thigh from the initial biopsies to determine the 
time-dependent changes in mTOR co-localization during recovery in CON and FED.
Skeletal muscle immunohistochemistry. Biopsy samples (~25 mg) were blotted and freed from any vis-
ible fat and connective tissue prior to being mounted in Optimal Cutting Temperature Compound (Tissue-Tek®, 
VWR) and frozen in isopentane cooled by liquid nitrogen prior to storage at −80 °C for subsequent immunoflu-
orescence analysis. Embedded muscle samples were fixed on the position in front of the blade of the microtome 
(Bright 5040, Bright Instrument Company limited, Huntingdon, England) and serial sections (5 μm) collected 
onto room temperature uncoated glass slides (VWR international, UK). Sections were left to air dry at room 
temperature for 10 min to remove excess crystallized water inside sections under storage.
Sections (5 μm) were fixed in acetone and ethanol (3:1) solution (Fisher technology) for 5 min and then 
washed for 3 × 5 min in phosphate buffered saline (PBS) to remove fixation reagent. Sections were subsequently 
pre-incubated with 5% normal goat serum for 30 min, the PBS wash step repeated, prior to incubation (2 h) in pri-
mary antibody solution diluted with 5% normal goat serum (Invitrogen, UK). Following incubation, sections were 
washed for 3 × 5 min in PBS and incubated in the appropriate secondary antibody for 30 min at room temperature. 
Sections were finally incubated with wheat Germ Agglutinin (WGA-350) for 20 min at room temperature to mark 
the sarcolemmal membrane. Slides were left to air dry until the visual water stains evaporated for 1–2 min at room 
temperature. Then sections were mounted with 20 µL Mowiol® 4–88 (Sigma-Aldrich, UK) and sealed by glass cov-
erslips to protect the muscle sections and to preserve fluorescence signals. Slides were left overnight before obser-
vation. All primary antibodies, corresponding secondary antibodies and working dilutions are listed in Table 1.
Antibody validation experiments. To confirm antibody specificity we employed anti-
gen competition assays using synthetic peptides (Pepceuticals, Ltd, UK) generated against Rheb 
(QFVDSYDPTIENTFTKLITVNGQEYHLQLVDTAGQDEYSIFPQTYSIDING) and against eIF3f 
(CVDSYERRNEGAARV). This approach was not appropriate for TSC2 given that a fusion protein was used for 
antibody synthesis. Therefore we employed the recombinant TSC2 protein used in antibody generation (kindly 
provided by Abbgent, USA). In each case, the antibody was incubated with saturating concentrations (10 times 
higher than the antibody concentration) of the antigen peptide (Rheb, eIF3F) or recombinant protein (TSC2) 
for 24 h at 4 °C, prior to application onto human skeletal muscle sections in place of primary antibody. All other 
stages of the staining protocol were performed as described previously, with competition staining performed 
alongside a negative control in which the primary antibody was omitted completely. For mTOR, Rheb and TSC2 
antibody specificity experiments, skeletal muscle cross-sections were obtained from the Tibialis Anterior mus-
cle of mTOR conditional knock-out mouse samples or ‘floxed’ littermate controls21, or plantaris muscle from 
tamoxifen-inducible, muscle-specific iRheb and iTSC2 knockout mice compared to sham controls22. Rheb and 
TSC2 imKO samples were generated as previously described22. Briefly, animals received an initial 5-day treatment 
of Tamoxifen (2 mg/day), followed by 14 days without treatment, and then finally by a second round of Tamoxifen 
(1 mg/day) administration for 14 days. Samples were visualized as previously described for human samples.
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Image capture. Prepared slides were observed under a Nikon E600 microscope using a 40 × 0.75 numerical 
aperture objective. Images per area were captured under three colour filters achieved by a SPOT RT KE colour 
three shot CCD camera (Diagnostic Instruments Inc., MI, USA), illuminated by a 170 W Xenon light source. For 
images capture, DAPI UV (340–380 nm) filter was used to view WGA-350 (blue) signals and mTOR stains tagged 
with Alexa 594 fluorophore (red) was visualised under the Texas red (540–580 nm) excitation filter. FITC (465–
495 nm) excitation filter was left to capture signals of mTOR-associated proteins, which were conjugated with 
Alexa Fluor 488 fluorophore unless stated otherwise (Table 1). DAPI UV (340–380 nm) was also used to observe 
the DAPI stained nucleus. All widefield images were obtained using a 40x objective (0.75 NA). Co-localisation 
experiments between mTOR and associated proteins were performed on an upright confocal microscope (Zeiss 
LSM 510 Meta, Carl Zeiss), using a 40 × 1.4 NA water immersion objective. Fluorophores were visualised under 
three laser filters simultaneously. Alexa Fluor 488 fluorophore was excited by an argon laser and 498–571 nm 
emission, while a 594 nm line of the helium–neon laser with 601–713 nm emission was used to excite Alexa Fluor 
594 fluorophore. WGA conjugated with Alexa 350 and DAPI could be visualised under the excitation of the 
405 nm line from a Diode 405–30 filter.
For total protein quantification, 3 slide replicates for each individual were stained, imaged and quantified. At 
least 7 images were captured per section with each image including ~6 fibres on average. For each subject, muscle 
samples were taken from four time points, and averaged values were calculated from two sections (repeats) for 
each time point. As such, the total fibre numbers analyzed for each subject was ~240–336 fibres.
All image processing and quantitation was carried out in ImagePro Plus 5.1 and kept constant between images, 
including exposure time, gain, and image frame. Total protein fluorescence intensity was quantified by measuring 
the signal intensity within the intracellular regions of a mask created by a specific membrane marker (dystrophin, 
WGA). For colocalisation analysis, five to seven areas per section were randomly selected and imaged under 
the same capture settings. Images were processed and analysed under the Image-Pro Plus 5.1 software (Media 
Cybernetics, MD, USA). Prior to colocalisation analysis, all images underwent a no neighbour deconvolution 
algorithm as a filter. Image signals generated by WGA or dystrophin were used to estimate cell membrane bor-
ders, which were merged with the corresponding target protein images to identify the association between the 
protein of interest and the plasma membrane. Pearson’s correlation coefficient (Image-Pro software) was used to 
quantify localization with the plasma membrane and mTOR associated proteins.
S6K1 and AKT activity assays. 50 mg of muscle was used for the measurement of S6K1 and AKT activity 
as previously described45.
Statistical Analysis. Immunofluorescence image analysis was performed in duplicate, with 5–7 regions per 
cross section used for analysis. Pearson’s correlation coefficient values at each group/time point were analyzed 
using a two-way ANOVA (Prism, Graphpad) with Tukeys post-hoc analysis where appropriate. Significance was 
set at P < 0.05. Data are presented as Mean ± SEM and reported relative to the baseline biopsy (i.e. −40 min time-
point) in the CON group (PRE-EX CON).
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